Liu Y, Meng J, & Wang G. (2018). Risk of selected gastrointestinal toxicities associated with poly (ADP-ribose) polymerase (PARP) inhibitors in the treatment of ovarian cancer: A meta-analysis of published trials. Dove Medical Press.
Chicago Style (17th ed.) CitationLiu Y, Meng J, and Wang G. Risk of Selected Gastrointestinal Toxicities Associated with Poly (ADP-ribose) Polymerase (PARP) Inhibitors in the Treatment of Ovarian Cancer: A Meta-analysis of Published Trials. Dove Medical Press, 2018.
MLA (9th ed.) CitationLiu Y, et al. Risk of Selected Gastrointestinal Toxicities Associated with Poly (ADP-ribose) Polymerase (PARP) Inhibitors in the Treatment of Ovarian Cancer: A Meta-analysis of Published Trials. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.